NCT06804850 2025-11-19
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC
West China Hospital
Phase 2 Withdrawn
West China Hospital
University of California, San Diego
Institut de cancérologie Strasbourg Europe
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of California, San Diego
University Hospital Center of Martinique